Literature DB >> 31782998

Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy: Clinical Evaluation and Identification of the Genetic Basis.

Jorge L Alió Del Barrio1, Doug D Chung2, Olena Al-Shymali3, Alice Barrington2, Kavya Jatavallabhula2, Vinay S Swamy2, Pilar Yébana3, Maria Angélica Henríquez-Recine4, Ana Boto-de-Los-Bueis4, Jorge L Alió1, Anthony J Aldave5.   

Abstract

PURPOSE: This study reports the clinical features and genetic bases of 3 previously unreported families with punctiform and polychromatic pre-Descemet corneal dystrophy (PPPCD).
DESIGN: Observational case series.
METHODS: Full ophthalmic assessment was performed for members of 3 unreported families with PPPCD. Structural and biomechanical alterations of the cornea were screened. Whole exome sequencing (WES) was performed in the first family. Novel or rare variants that segregated with the affected status were screened in the other 2 families using Sanger sequencing. Identified variants that segregated with the affected status in all families were characterized by using in silico prediction tools and/or in vitro splice assays. Additionally, 2 previously reported PPPCD families were screened for variants identified in the 3 unreported PPPCD families.
RESULTS: PPPCD was diagnosed in 12 of the 21 examined members of the 3 unreported families. The only refractive, topographic, or biomechanical abnormality associated with PPPCD was a significantly increased corneal stiffness. WES and Sanger sequencing identified 2 variants that segregated with the affected status in all 3 families: a rare intronic PDZD8 c.872+10A>T variant and a novel missense PRDX3 c.568G>C (p.Asp190His) variant. The same PRDX3 variant was identified in the previously reported PPPCD family expressing the common PPPCD phenotype and was predicted by in silico prediction tools to be damaging to protein function.
CONCLUSIONS: PPPCD is associated with an alteration of corneal biomechanics and a novel missense variant in PRDX3. Screening of additional families will determine whether all families demonstrate a PRDX3 variant or whether locus heterogeneity may exist for PPPCD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31782998      PMCID: PMC7113114          DOI: 10.1016/j.ajo.2019.11.024

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  25 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  IC3D classification of corneal dystrophies--edition 2.

Authors:  Jayne S Weiss; Hans Ulrik Møller; Anthony J Aldave; Berthold Seitz; Cecilie Bredrup; Tero Kivelä; Francis L Munier; Christopher J Rapuano; Kanwal K Nischal; Eung Kweon Kim; John Sutphin; Massimo Busin; Antoine Labbé; Kenneth R Kenyon; Shigeru Kinoshita; Walter Lisch
Journal:  Cornea       Date:  2015-02       Impact factor: 2.651

3.  Heredity and in vivo confocal microscopy of punctiform and polychromatic pre-Descemet dystrophy.

Authors:  María Angélica Henríquez-Recine; Kelly Sonia Marquina-Lima; Elena Vallespín-García; Sixto García-Miñaur; José Manuel Benitez Del Castillo; Ana Boto de Los Bueis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-04       Impact factor: 3.117

4.  Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells.

Authors:  Zhilei Liu; Yadong Hu; Haisha Liang; Zhongyuan Sun; Shan Feng; Haiteng Deng
Journal:  J Proteome Res       Date:  2016-03-24       Impact factor: 4.466

5.  Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display.

Authors:  A F Muro; M Caputi; R Pariyarath; F Pagani; E Buratti; F E Baralle
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Overexpression of peroxiredoxin in human breast cancer.

Authors:  D Y Noh; S J Ahn; R A Lee; S W Kim; I A Park; H Z Chae
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

7.  Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.

Authors:  Vuokko L Kinnula; S Lehtonen; R Sormunen; R Kaarteenaho-Wiik; S W Kang; S G Rhee; Y Soini
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

8.  Punctiform and Polychromatophilic Dominant Pre-Descemet Corneal Dystrophy.

Authors:  Lisa Lagrou; Julian Midgley; Kenneth Gerald Romanchuk
Journal:  Cornea       Date:  2016-04       Impact factor: 2.651

9.  Predicting the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Gregory E Sims; Sean Murphy; Jason R Miller; Agnes P Chan
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

10.  CADD: predicting the deleteriousness of variants throughout the human genome.

Authors:  Philipp Rentzsch; Daniela Witten; Gregory M Cooper; Jay Shendure; Martin Kircher
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  1 in total

1.  Confirmation of PRDX3 c.568G>C as the Genetic Basis of Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy.

Authors:  Charlene H Choo; Ana Boto de Los Bueis; Doug D Chung; Anthony J Aldave
Journal:  Cornea       Date:  2021-08-05       Impact factor: 3.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.